What drives the current move in ALMDP.PA stock?

The pre-market spike in ALMDP.PA stock is driven by high volume **149,072**, a low float and intraday price action around **€0.35**. Traders see an oversold bounce setup; clinical news or financing updates would be the primary catalysts.

What are the main risks for ALMDP.PA stock investors?

Key risks include negative earnings, low cash per share **€0.01**, potential dilution and dependency on clinical readouts. ALMDP.PA stock has tight liquidity and can move quickly on small news items.

What price target should traders watch for ALMDP.PA stock?

Meyka AI's model projects a 12-month baseline target **€0.60** for ALMDP.PA stock. Short-term resistance sits near **€0.40**; a break above **€0.37** on strong volume supports the projected path.

How should I trade an oversold bounce in ALMDP.PA stock?

Trade small size, set a stop-loss near **€0.30**, and use a take-profit around **€0.60** if volume confirms the bounce. Monitor trial news and funding updates closely for shifts in risk.

EU Stocks

ALMDP.PA Medesis Pharma (EURONEXT) €0.35 pre-market 17 Jan 2026: oversold bounce

ByDanny Kontos January 17, 2026

Pre-market trading shows ALMDP.PA stock at €0.35 on 17 Jan 2026 with volume 149,072 versus an average 15,909, signalling a possible oversold bounce. Investors should weigh the short-term technical signal against weak fundamentals: EPS -0.59, negative book value and a market cap €1,801,314.00. We outline the bounce setup, a risk-aware trade plan and a model forecast for traders and long-term watchers.